首页    期刊浏览 2024年11月29日 星期五
登录注册

文章基本信息

  • 标题:Efeitos Metabólicos da Terapia Antirretroviral em Mulheres vivendo com HIV/AIDS
  • 本地全文:下载
  • 作者:Matheus Alves dos Santos ; Erildo Vicente Muller ; Camila Marinelli Martins
  • 期刊名称:Research, Society and Development
  • 电子版ISSN:2525-3409
  • 出版年度:2022
  • 卷号:11
  • 期号:1
  • 页码:1-9
  • DOI:10.33448/rsd-v11i1.25409
  • 语种:English
  • 出版社:Grupo de Pesquisa Metodologias em Ensino e Aprendizagem em Ciências
  • 摘要:Cultural inequalities that are harmful to women can potentialize the risk of HIV in this group. The aim of this research was to draw the epidemiological and metabolic profile of women diagnosed with HIV. It consists in a cross-sectional analysis of a cohort study, performed in women living with HIV/AIDS that received antiretroviral therapy (ARV) and that were users of the Specialized Care Service in the municipality of Ponta Grossa – PR, between 2003 and 2018. The analysis was descriptive and the association between the medicines used and the metabolic changes were evaluated with relative risk (RR) and through the chi-squared test. Medical records of 451 women were analyzed: 80,5% were white, 44,4% were married, 88,2% contracted HIV by sexual transmission and 83,1% were heterosexual. There was significant association as a risk factor between the use of Protease Inhibitors (PI) and alterations on HDL cholesterol (RR = 1,70, IC95% 1,32-2,20 and p<0,01) and triglycerides levels (RR = 1,29, IC 95% 1,01-1,65 and p= 0,04). As a protective factor, there was a significant association between Non-nucleoside Reverse Transcriptase Inhibitors (NNRTI) and changes in HDL cholesterol levels (RR = 0,66, IC95% 0,53-0,82 and p<0,01). The study has shown association between ARV and metabolic changes in women, specially PI and NNRTI with HDL cholesterol and triglycerides, suggesting the necessity of other drug options for patients with higher cardiovascular risk.
  • 关键词:HIV;AIDS;Women;Antiretroviral;Metabolic.
国家哲学社会科学文献中心版权所有